MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Mobile and electronic health-supported physical activity in Parkinson’s disease: A scoping review

    M. Bopp, J. Krell-Roesch, Y. Geda, S. Aslam, A. Woll (Karlsruhe, Germany)

    Objective: To conduct an overview of current research on mobile and electronic (m- and e-) health-supported physical activity (PA) programs in persons with Parkinson’s disease…
  • 2023 International Congress

    Assessing non-motor symptoms and associations with quality of life among patients in Korle-Bu Teaching Hospital, Ghana

    D. Brodie-Mends, F. Duodu, K. Nkromah, A. Akpalu (Accra, Ghana)

    Objective: To determine the prevalence and types of non-motor symptoms (NMS) and their relation to quality of life among Parkinson’s disease (PD) patients who attend…
  • 2023 International Congress

    Decreased occurrence of dyskinesia when combining amantadine to L-DOPA in early Parkinson disease (PD): the PREMANDYSK trial

    O. Rascol, F. Ory-Magne, JP. Azulay, L. Defebvre, JL. Houeto, D. Maltete, P. Remy, A. Foubert-Samier, A. Sommet, C. Thalamas, S. Thobois, JC. Corvol, N. Ns-Park/fcrin (Toulouse, France)

    Objective: To assess amantadine effects on dyskinesia and other PD symptoms when adjunct to L-DOPA in early PD. Background: Amantadine is efficacious on L-DOPA-induced dyskinesia…
  • 2023 International Congress

    Progressive cortical cerebrovascular reactivity reduction occurs in Parkinson’s disease: a longitudinal study

    LR. Jin (Shanghai, China)

    Objective: In the longitudinal study, we aimed to investigate regional cerebrovascular reactivity (CVR) changes in the patients with PD at baseline and during a 2-year…
  • 2023 International Congress

    Genetic subtypes of Parkinson’s disease in a Colorado clinic

    M. Lafreniere, G. Bosma, E. Forbes (Aurora, USA)

    Objective: The objective of this study is to investigate the natural history of genetic subtypes of Parkinson’s disease (PD) and characterize the genetic architecture of…
  • 2023 International Congress

    Parkinson’s disease and physiotherapy: perspectives in functional health education and innovation in digital media

    S. Souza, A. Silva, V. Israel (CURIIBA, Brazil)

    Objective: To identify and develop virtual functional health education content aimed at people with PD and to verify the reach profile on social media. Background:…
  • 2023 International Congress

    Impact of deep brain stimulation of the subthalamic nuclei on non-motor symptoms in Parkinson’s disease: a monocentric prospective study with a 12-month follow-up

    V. Leclercq, V. Donckels, E. Hanon, S. Dethy (Sint-Pieters-Leeuw, Belgium)

    Objective: The aim of the study is to evaluate the evolution of non-motor symptoms in Parkinson's disease (PD) in patients treated with deep brain stimulation…
  • 2023 International Congress

    Long-term safety and durability of effect of ecopipam in pediatric patients with Tourette Syndrome: Results of a 12-month open-label extension (OLE) study

    D. Gilbert, D. Kim, M. Miller, S. Horine, K. Saljooqi, G. Karkanias, S. Wanaski, T. Cunniff (Cincinnati, USA)

    Objective: Assess the safety and durability of effect of long-term treatment with ecopipam in pediatric patients with Tourette syndrome (TS). Background: TS is a childhood-onset…
  • 2023 International Congress

    Association of Early and late age of onset with Mitochondrial DNA haplogroup in Indian Spinocerebellar Ataxia type- 2 patients.

    A. Sonakar, M. Srivastava, M. Faruq, A. Srivastava (NEW DELHI, India)

    Objective: To explore the role of mtHaplogroups in early and late onset SCA2 patients. Background: An unstable expansion of a CAG tract in the ATXN2…
  • 2023 International Congress

    Association between changes in hippocampal volumes, cognition, and CSF markers in Parkinson’s Disease

    S. Becker, O. Granert, C. Schulte, K. Brockmann, B. Roeben, M. Bode, M. Timmers, K. Scheffler, W. Maetzler, D. Berg, I. Liepelt-Scarfone (Calgary, Canada)

    Objective: To assess whether changes in hippocampal subfield volumes are associated with cognition or CSF β-amyloid 1–42 (Aβ42) levels in Parkinson’s Disease (PD). Background: Hippocampal…
  • « Previous Page
  • 1
  • …
  • 162
  • 163
  • 164
  • 165
  • 166
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley